| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 09/26/2023 | REATA PHARMACEUTICALS INC | RETA | Disposition | Stock Option (right to buy) | 2k | $25.52 | $51k | | 09/26/2023 |
| 09/26/2023 | REATA PHARMACEUTICALS INC | RETA | Disposition | Stock Option (right to buy) | 8k | $39.48 | $315.8k | | 09/26/2023 |
| 09/26/2023 | REATA PHARMACEUTICALS INC | RETA | Disposition | Stock Option (right to buy) | 9k | $88.75 | $798.8k | | 09/26/2023 |
| 09/26/2023 | REATA PHARMACEUTICALS INC | RETA | Disposition | Class A common stock | 6k | $0.00 | $0 | | 09/26/2023 |
| 09/26/2023 | REATA PHARMACEUTICALS INC | RETA | Disposition | Stock Option (right to buy) | 6.3k | $130.92 | $824.8k | | 09/26/2023 |
| 09/26/2023 | REATA PHARMACEUTICALS INC | RETA | Disposition | Stock Option (right to buy) | 5k | $146.01 | $730k | | 09/26/2023 |
| 09/26/2023 | REATA PHARMACEUTICALS INC | RETA | Disposition | Stock Option (right to buy) | 99 | $27.32 | $2.7k | | 09/26/2023 |
| 09/26/2023 | REATA PHARMACEUTICALS INC | RETA | Disposition | Stock Option (right to buy) | 416 | $34.76 | $14.5k | | 09/26/2023 |
| 09/26/2023 | REATA PHARMACEUTICALS INC | RETA | Disposition | Stock Option (right to buy) | 5.6k | $34.76 | $195.4k | | 09/26/2023 |
| 09/26/2023 | REATA PHARMACEUTICALS INC | RETA | Disposition | Stock Option (right to buy) | 135 | $93.61 | $12.6k | | 09/26/2023 |
| 09/26/2023 | REATA PHARMACEUTICALS INC | RETA | Disposition | Stock Option (right to buy) | 2.1k | $93.61 | $200k | | 09/26/2023 |
| 09/26/2023 | REATA PHARMACEUTICALS INC | RETA | Disposition | Stock Option (right to buy) | 4.5k | $26.46 | $119.1k | | 09/26/2023 |
| 06/07/2023 | REATA PHARMACEUTICALS INC | RETA | Grant | Class A common stock | 106 | $93.61 | $9.9k | | 06/07/2023 |
| 06/07/2023 | REATA PHARMACEUTICALS INC | RETA | Grant | Class A common stock | 1.7k | $93.61 | $157.5k | | 06/07/2023 |
| 06/07/2023 | REATA PHARMACEUTICALS INC | RETA | Grant | Stock Option (right-to-buy) | 135 | $93.61 | $12.6k | | 06/07/2023 |
| 06/07/2023 | REATA PHARMACEUTICALS INC | RETA | Grant | Stock Option (right-to-buy) | 2.1k | $93.61 | $200k | | 06/07/2023 |
| 04/04/2023 | Apollo Endosurgery, Inc. | APEN | Disposition | Common Stock | 39.2k | $0.00 | $0 | | 04/04/2023 |
| 04/04/2023 | Apollo Endosurgery, Inc. | APEN | Disposition | Common Stock | 2k | $0.00 | $0 | by Trust | 04/04/2023 |
| 04/04/2023 | Apollo Endosurgery, Inc. | APEN | Disposition | Stock Option (Right to Buy) | 1.4k | $3.36 | $4.8k | | 04/04/2023 |
| 04/04/2023 | Apollo Endosurgery, Inc. | APEN | Disposition | Non-Qualified Stock Option (right to buy) | 4.8k | $6.50 | $31.5k | | 04/04/2023 |
| 04/04/2023 | Apollo Endosurgery, Inc. | APEN | Disposition | Stock Option (Right to Buy) | 9.8k | $6.58 | $64.8k | | 04/04/2023 |
| 04/04/2023 | Apollo Endosurgery, Inc. | APEN | Disposition | Non-Qualified Stock Option (right to buy) | 16.5k | $3.27 | $54.1k | | 04/04/2023 |
| 04/04/2023 | Apollo Endosurgery, Inc. | APEN | Disposition | Stock Option (Right to Buy) | 28.4k | $2.08 | $59.2k | | 04/04/2023 |
| 04/04/2023 | Apollo Endosurgery, Inc. | APEN | Disposition | Non-Qualified Stock Option (right to buy) | 5.3k | $8.86 | $46.7k | | 04/04/2023 |
| 04/04/2023 | Apollo Endosurgery, Inc. | APEN | Disposition | Stock Option (Right to Buy) | 19.3k | $3.95 | $76.4k | | 04/04/2023 |
| 06/14/2022 | Apollo Endosurgery, Inc. | APEN | Grant | Stock Option (Right to Buy) | 19.3k | $3.95 | $76.4k | | 06/14/2022 |
| 06/14/2022 | Apollo Endosurgery, Inc. | APEN | Grant | Common Stock | 14.2k | $0.00 | $0 | | 06/14/2022 |
| 06/08/2022 | REATA PHARMACEUTICALS INC | RETA | Grant | Stock Option (right-to-buy) | 416 | $34.76 | $14.5k | | 06/08/2022 |
| 06/08/2022 | REATA PHARMACEUTICALS INC | RETA | Grant | Stock Option (right-to-buy) | 5.6k | $34.76 | $195.4k | | 06/08/2022 |
| 06/08/2022 | REATA PHARMACEUTICALS INC | RETA | Grant | Class A common stock | 287 | $34.76 | $10k | | 06/08/2022 |
| 06/08/2022 | REATA PHARMACEUTICALS INC | RETA | Grant | Class A common stock | 3.9k | $34.76 | $135k | | 06/08/2022 |
| 01/03/2022 | REATA PHARMACEUTICALS INC | RETA | Grant | Stock Option (right to buy) | 99 | $27.32 | $2.7k | | 01/03/2022 |
| 01/03/2022 | REATA PHARMACEUTICALS INC | RETA | Grant | Class A common stock | 59 | $27.32 | $1.6k | | 01/03/2022 |
| 06/17/2021 | Apollo Endosurgery, Inc. | APEN | Grant | Common Stock | 3.9k | $0.00 | $0 | | 06/17/2021 |
| 06/17/2021 | Apollo Endosurgery, Inc. | APEN | Grant | Non-Qualified Stock Option (right to buy) | 5.3k | $8.86 | $46.7k | | 06/17/2021 |
|